ZLAB 内幕交易
ZLAB 的 SEC Form 4 内幕交易记录
总交易
112
买入
2
买入总额
$66K
卖出总额
$14.9M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(45) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $19.03 | $951K | 2026-03-09 | CEO卖出, 董事卖出 |
| ★★★★★(45) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $19.42 | $971K | 2026-03-06 | CEO卖出, 董事卖出 |
| ★★★★★(45) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $19.22 | $961K | 2026-03-05 | CEO卖出, 董事卖出 |
| ★★★★★(45) | DU YING | Chairperson & CEO | 卖出 | 35,710 | $19.32 | $690K | 2026-03-04 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 7,026 | $18.53 | $130K | 2026-06-30 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 24,543 | $17.46 | $429K | 2026-06-26 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $20.74 | $1.0M | 2026-05-15 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $20.09 | $1.0M | 2026-05-14 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 2,653 | $20.45 | $54K | 2026-04-06 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 5,576 | $20.39 | $114K | 2026-04-02 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 1,067 | $19.08 | $20K | 2026-03-11 | CEO卖出, 董事卖出 |
| ★★★★★(40) | DU YING | Chairperson & CEO | 卖出 | 14,290 | $18.78 | $268K | 2026-03-04 | CEO卖出, 董事卖出 |
| ★★★★★(35) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 98,653 | $26.18 | $2.6M | 2026-08-20 | C-suite卖出, 百万级卖出 |
| ★★★★★(35) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $19.00 | $950K | 2026-05-18 | CEO卖出, 董事卖出 |
| ★★★★★(35) | DU YING | Chairperson & CEO | 卖出 | 33,769 | $20.22 | $683K | 2026-05-13 | CEO卖出, 董事卖出 |
| ★★★★★(35) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $19.20 | $960K | 2026-05-13 | CEO卖出, 董事卖出 |
| ★★★★★(35) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $18.28 | $914K | 2026-03-04 | CEO卖出, 董事卖出 |
| ★★★★★(33) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 15,569 | $19.06 | $297K | 2026-03-05 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(30) | DU YING | Chairperson & CEO | 卖出 | 16,231 | $19.44 | $316K | 2026-05-13 | CEO卖出, 董事卖出 |
| ★★★★★(28) | CHEN YAJING | Chief Financial Officer | 卖出 | 2,264 | $17.46 | $40K | 2026-06-26 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | CHEN YAJING | Chief Financial Officer | 卖出 | 853 | $20.45 | $17K | 2026-04-06 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | CHEN YAJING | Chief Financial Officer | 卖出 | 5,199 | $20.39 | $106K | 2026-04-02 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(28) | CHEN YAJING | Chief Financial Officer | 卖出 | 1,703 | $18.63 | $32K | 2026-03-13 | CFO卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 3,017 | $20.45 | $62K | 2026-04-06 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 9,614 | $20.39 | $196K | 2026-04-02 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(25) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 1,966 | $18.63 | $37K | 2026-03-13 | C-suite卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | CHEN YAJING | Chief Financial Officer | 卖出 | 260 | $27.00 | $7K | 2026-08-19 | CFO卖出 |
| ★★★★★(18) | CHEN YAJING | Chief Financial Officer | 卖出 | 619 | $25.00 | $15K | 2026-08-11 | CFO卖出 |
| ★★★★★(18) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 4,103 | $17.46 | $72K | 2026-06-26 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 1,224 | $20.45 | $25K | 2026-04-06 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 2,739 | $20.45 | $56K | 2026-04-06 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 9,910 | $20.39 | $202K | 2026-04-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 4,194 | $20.39 | $86K | 2026-04-02 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 1,281 | $18.63 | $24K | 2026-03-13 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 2,957 | $18.63 | $55K | 2026-03-13 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(18) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 10,000 | $17.38 | $174K | 2026-03-03 | 高管卖出, 非10b5-1计划卖出 |
| ★★★★★(15) | GAYNOR RICHARD | - | 买入 | 1,736 | $19.05 | $33K | 2026-07-01 | 董事买入 |
| ★★★★★(15) | GAYNOR RICHARD | - | 买入 | 1,731 | $18.91 | $33K | 2026-03-17 | 董事买入 |
| ★★★★★(10) | LIS WILLIAM | - | 卖出 | 8,506 | $25.00 | $213K | 2026-08-12 | 董事卖出 |
| ★★★★★(10) | LIS WILLIAM | - | 卖出 | 7,040 | $18.09 | $127K | 2026-06-22 | 董事卖出 |
| ★★★★★(8) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 3,517 | $20.19 | $71K | 2026-05-14 | 高管卖出 |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 315 | $25.50 | $8K | 2026-10-01 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 920 | - | - | 2026-10-01 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 1,250 | - | - | 2026-08-14 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 427 | $25.90 | $11K | 2026-08-14 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 11,048 | - | - | 2026-07-02 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 80,393 | - | - | 2026-07-02 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 4,348 | $19.12 | $83K | 2026-07-02 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 18,000 | - | - | 2026-07-01 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 7,083 | $19.15 | $136K | 2026-07-01 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 58,800 | - | - | 2026-06-25 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 6,250 | - | - | 2026-06-25 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 14,600 | - | - | 2026-06-25 | |
| ★★★★★(0) | LIS WILLIAM | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | WIRTH PETER | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | VOUNATSOS MICHEL | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | MOULDER LEON O JR | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | DIEKMAN JOHN D | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | GAYNOR RICHARD | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | LEUNG NISA | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | MORRISON SCOTT W | - | 卖出 | 22,371 | - | - | 2026-06-17 | |
| ★★★★★(0) | WANG YIZHE | Operating Partner | 卖出 | 136,819 | - | - | 2026-05-11 | |
| ★★★★★(0) | WANG YIZHE | Operating Partner | 卖出 | 59,288 | - | - | 2026-05-11 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 53,850 | - | - | 2026-05-27 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 33,993 | - | - | 2026-05-27 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 19,857 | - | - | 2026-05-26 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 261,092 | - | - | 2026-05-19 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 117,435 | $18.75 | $2.2M | 2026-05-19 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $1.74 | $87K | 2026-05-18 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $1.74 | $87K | 2026-05-15 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | - | - | 2026-05-14 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | - | - | 2026-05-13 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 7,145 | - | - | 2026-04-02 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 5,391 | - | - | 2026-04-02 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 5,031 | - | - | 2026-04-02 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 6,750 | - | - | 2026-04-02 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 2,500 | - | - | 2026-04-02 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 1,500 | - | - | 2026-04-01 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 3,400 | - | - | 2026-04-01 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 10,800 | - | - | 2026-04-01 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 13,758 | - | - | 2026-04-01 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 19,523 | - | - | 2026-04-01 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 830 | - | - | 2026-04-01 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 2,671 | - | - | 2026-04-01 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 13,758 | - | - | 2026-04-01 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 32,062 | - | - | 2026-04-01 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 17,887 | - | - | 2026-03-04 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 14,905 | - | - | 2026-03-04 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 11,924 | - | - | 2026-03-04 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 11,924 | - | - | 2026-03-04 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 25,579 | - | - | 2026-03-04 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 4,258 | - | - | 2026-03-12 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 6,388 | - | - | 2026-03-12 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 4,258 | - | - | 2026-03-12 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 5,323 | - | - | 2026-03-12 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 32,419 | - | - | 2026-03-11 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 353,430 | - | - | 2026-03-11 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 27,027 | - | - | 2026-03-04 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 27,027 | - | - | 2026-03-04 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 103,950 | - | - | 2026-03-04 | |
| ★★★★★(0) | CHEN YAJING | Chief Financial Officer | 卖出 | 83,160 | - | - | 2026-03-04 | |
| ★★★★★(0) | SMILEY JOSHUA L | President and Chief Operating Officer | 卖出 | 33,783 | - | - | 2026-03-04 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 33,783 | - | - | 2026-03-04 | |
| ★★★★★(0) | AMADO RAFAEL | President, Head of Global Oncology Research and Development | 卖出 | 103,950 | - | - | 2026-03-04 | |
| ★★★★★(0) | EDMONDSON FRAZOR TITUS III | Chief Legal Officer | 卖出 | 83,160 | - | - | 2026-03-04 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 116,936 | $19.41 | $2.3M | 2026-03-10 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 2,655 | - | - | 2026-03-10 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 261,092 | $1.74 | $454K | 2026-03-10 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $1.74 | $87K | 2026-03-09 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $1.74 | $87K | 2026-03-06 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | $1.74 | $87K | 2026-03-05 | |
| ★★★★★(0) | DU YING | Chairperson & CEO | 卖出 | 50,000 | - | - | 2026-03-04 |